病毒感染Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testing.
期刊:iScience发表年份:2026作者:Breanna Kim; Rachel Roenicke; Peyton M Roeder; Isabel Steinberg; Andy Patamawenu; Mitra Harrison; Freya Van't Veer; Emma Koory; Jane Xie; Tulley Shofner; Kenta Matsuda; Eleanor Wettstein; Ellison Ober; Ceanna Cooney; Tae Kim; Jonathan D Webber; Tyler
